A closer look at “First Bacterial Galactose Oxidase Unlocks Greener Drug and Food Ingredient Production”, exactly as the source publishes it. A newly discovered bacterial galactose oxidase could help the pharmaceutical and food industries replace harsh chemical oxidation with a cleaner, enzyme-driven process. Researchers have identified the first galactose oxidase of bacterial origin, expanding the biocatalytic toolkit for converting alcohols into valuable aldehydes and ketones. Unlike conventional methods that require toxic oxidants and high temperatures, this enzyme works under mild, aqueous conditions, reducing hazardous waste and energy use.
The finding is significant because galactose oxidases are prized for their ability to oxidize a wide range of alcohol substrates, including complex molecules used in drug synthesis and flavor production. Until now, only fungal versions were known, limiting industrial application due to stability and expression challenges. The bacterial enzyme offers potential advantages in production scalability and robustness. The full version stays on the original page, which this listing opens directly.